| Financial Year |
March 31 2023 |
| Monetary Funds |
94,002,778.46 |
| Held-for-trading Financial Assets |
6,023,571.38 |
| Notes Receivable |
-- |
| Accounts Receivable |
35,809,992.97 |
| Advances to Suppliers |
1,740,487.05 |
| Other Receivables |
8,646,646.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
75,423,235.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,870,633.22 |
| Total Current Assets |
224,517,345.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,359,012.30 |
| Investment Properties |
-- |
| Fixed Assetes |
87,952,204.90 |
| Under-construction Projects |
12,555.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,238,718.84 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,384,531.80 |
| Deferred Income Tax Assets |
1,100,755.47 |
| Other Non-Current Assets |
6,433,585.00 |
| Sub-Total of Non-Current Assets |
138,586,827.93 |
| Total Assets |
363,104,173.61 |
| Short-Term Loans |
34,045,527.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
33,105,443.52 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,056,582.52 |
| Taxes Payable |
470,286.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,658,562.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,683,865.21 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
104,777,550.69 |
| Long-term Loans |
11,940,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
14,549,644.56 |
| Total Liabilities |
119,327,195.25 |
| Paid-In Capital(Or Share Stock) |
117,000,000.00 |
| Capital Surplus |
260,534,833.63 |
| Surplus Reserve |
19,292,013.88 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-166,646,875.78 |
| Minority Stockholder's Interest |
13,597,006.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
230,179,971.73 |
| Owner's Equity（Stockholder's Equity） |
243,776,978.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
363,104,173.61 |
